Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

Avatar Contraception Communication Training

Study ID: NCT05995574
Start Date: 2026-04-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

166

Intervention / Treatment

avatar communication training

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Study ID: NCT07326540
Start Date: 2026-03-20
End Date: 2028-03-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

248

Intervention / Treatment

BV100 (300 mg)

Polymyxin B

Colistin

Ampicillin-Sulbactam

MEROPENEM 2 grams TID

Sponsor

BioVersys SAS

Source: clinicaltrials.gov

Share:
Add to list

Basal Cell Carcinoma Chemoprevention Trial

Study ID: NCT05212246
Start Date: 2026-05-01
End Date: 2032-05-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1630

Intervention / Treatment

5% Imiquimod cream

Placebo Vehicle Control Cream

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Study ID: NCT06796504
Start Date: 2026-03-31
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Procedure/Surgery: Implant Procedure

Disease-Modifying Therapies (DMTs)

Device: Active stimulation

Device: Non-active stimulation

Sponsor

SetPoint Medical Corporation

Source: clinicaltrials.gov

Share:
Add to list

Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation

Study ID: NCT07445035
Start Date: 2026-04-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

lower-limb exoskeleton

Standard medical treatment

Sponsor

Fu Jen Catholic University

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Study ID: NCT05048368
Start Date: 2026-10-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Larotinib

Sponsor

Sunshine Lake Pharma Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption

Study ID: NCT07081763
Start Date: 2026-05
End Date: 2030-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

191

Intervention / Treatment

Baricitinib 2 mg

Sirolimus 2 MG

Placebo of baricitinib 2 MG

Placebo of sirolimus 2 MG

Sponsor

ANRS, Emerging Infectious Diseases

Source: clinicaltrials.gov

Share:
Add to list

The Study Seeks to Determine Potential Correlations Between Ventilation and Hematological Alterations, Contributing to a Better Understanding of Its Physiological Effects and Optimizing Patient Management in Critical Care Settings.

Study ID: NCT07030114
Start Date: 2026-04
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

complete blood tests

mechanical ventilation (MV)

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Abdominal Surgery

Study ID: NCT07224711
Start Date: 2026-06-01
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

2290

Intervention / Treatment

Lidocaine HCl 0.8% in D5W

Sodium Chloride 0.9%

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER : a Pilot Study

Study ID: NCT07391332
Start Date: 2026-04-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Psychotherapy assisted by high-dose psilocybin (25mg or 40mg where appropriate)

Psychotherapy assisted by low-dose psilocybin (1 mg)

Sponsor

Nantes University Hospital

Source: clinicaltrials.gov

Share:
Add to list